GACI First Investment Company Publication of Pricing Supplements (8423C)
2022年10月14日 - 1:08AM
ＲＮＳを含む英国規制内ニュース （英語）
TIDMSH45
RNS Number : 8423C
GACI First Investment Company
13 October 2022
GACI First Investment Company - Publication of Pricing
Supplements
THIS ANNOUNCEMENT IS NOT FOR PUBLICATION, DISTRIBUTION OR
RELEASE, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR IN ANY
OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY
APPLICABLE LAW
13 October 2022
The following pricing supplements (together, the "Pricing
Supplements") are available for viewing:
The pricing supplement in relation to the issue of
U.S.$1,250,000,000 5.000 per cent. Green Notes due 2027 by GACI
First Investment Company (the "Issuer") under its Guaranteed Euro
Medium Term Note Programme (the "Programme"). A copy of such
pricing supplement can be viewed at:
http://www.rns-pdf.londonstockexchange.com/rns/8423C_1-2022-10-13.pdf
The pricing supplement in relation to the issue of
U.S.$1,250,000,000 5.250 per cent. Green Notes due 2032 by the
Issuer under the Programme. A copy of such pricing supplement can
be viewed at:
http://www.rns-pdf.londonstockexchange.com/rns/8423C_2-2022-10-13.pdf
The pricing supplement in relation to the issue of
U.S.$500,000,000 5.375 per cent. Green Notes due 2122 by the Issuer
under the Programme. A copy of such pricing supplement can be
viewed at:
http://www.rns-pdf.londonstockexchange.com/rns/8423C_3-2022-10-13.pdf
For further information, please contact:
investors@pif.gov.sa
DISCLAIMER - INTENDED ADDRESSEES
The Pricing Supplements must be read in conjunction with the
offering circular dated 27 September 2022 in respect of the
Programme (the "Offering Circular").
Please note that the information contained in the Pricing
Supplements and the Offering Circular may be addressed to and/or
targeted at persons who are residents of particular countries
(specified in the Pricing Supplements and/or Offering Circular)
only and is not intended for use and should not be relied upon by
any person outside these countries and/or to whom the offer
contained in the Pricing Supplements and/or Offering Circular is
not addressed. Prior to relying on the information contained in the
Offering Circular you must ascertain from the Pricing Supplements
and Offering Circular whether or not you are part of the intended
addressees of the information contained therein.
The Pricing Supplements do not constitute an offer to sell or
the solicitation of an offer to buy securities in the United States
or in any other jurisdiction in which such offer, solicitation or
sale would be unlawful prior to registration, exemption from
registration or qualification under the securities law of any such
jurisdiction. The securities referred to in the Pricing Supplements
have not been and will not be registered under the United States
Securities Act of 1933, as amended (the "Securities Act") and may
not be offered or sold in the United States absent registration or
an exemption from registration under the Securities Act, and the
rules and regulations thereunder. The Issuer does not intend to
register the securities referred to in the Pricing Supplements in
the United States or to conduct a public offering of the securities
referred to in the Pricing Supplements in the United States or
elsewhere.
Your right to access this service is conditional upon complying
with the above requirement.
No offer or invitation to acquire any securities is being made
pursuant to this announcement.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PFTFLFISISLVLIF
(END) Dow Jones Newswires
October 13, 2022 12:08 ET (16:08 GMT)
Gaci 2122 (LSE:SH45)
過去 株価チャート
から 10 2024 まで 11 2024
Gaci 2122 (LSE:SH45)
過去 株価チャート
から 11 2023 まで 11 2024
